$ cat ./records/gates-foundation-joins-global-health-security-agenda-to-strengthe-2014.txt
Gates Foundation Joins Global Health Security Agenda to Strengthen 70-Nation Outbreak Detection
[RECORD.TXT] · cat --full
The Gates Foundation became a founding non-governmental member of the Global Health Security Agenda (GHSA), a coalition of more than 70 countries and international organisations launched in February 2014 to accelerate implementation of the WHO International Health Regulations. GHSA works to build national capacity to prevent, detect, and respond to infectious disease threats — the three pillars Gates had identified as most underfunded in global preparedness. Gates Foundation support helped finance laboratory capacity assessments, biosafety training, and emergency operations centre development across GHSA member countries.
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Supports Gavi Oral Cholera Vaccine Emergency Stockpile for Outbreak Response
Next →
Gates Foundation and Wellcome Trust Jointly Fund Ebola Vaccine and Therapeutics Research
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.